Chronic mucocutaneous Candidiasis, familial

Last updated on: 15.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Familial chronic mucocutaneous candidiasis (CMC) comprises a group of rare, phenotypically related or identical but genetically heterogeneous diseases with altered immune responses (often) selectively directed against Candida, characterized by persistent and/or recurrent infections of the skin, nails, and mucous membranes.

ClassificationThis section has been translated automatically.

CMC type 1 (CANDF1;familial candidiasis-1) mutation in a gene at chromosome 2p.

CMCtype 2 (CANDF2; OMIM:212050) mutation in the CARD9 gene (607212) at chromosome 9q34.3.

CMC type 3 (CANDF3; OMIM:607644), a form restricted to hand and toenails, gene is located at chromosome 11.

CMC type 4 (CANDF4; OMIM: 613108) mutation in CLEC7A gene (606264) at chromosome 12p13.

CMC type 5 (CANDF5; OMIM: 613953) A form of familial candidiasis previously thought to be isolated. It was originally named CANDF5 and is caused by a mutation in the IL17RA gene . In fact, this clinical picture is part of a primaryimmunodeficiency (immunodeficiency 51) that, in addition to a tendency to recurrent candia infections, includes staphylococcal skin infections and increased susceptibility to chronic bacterial respiratory infections (Zuccarello D et al. 2002).

CMC type 6 (CANDF6; OMIM:613956) mutation in the IL17F gene (606496) at chromosome 6p12.

CMC type 7 (CANDF7;OMIM:614162=immune deficiency31B/C) mutation in STAT1 gene (600555) at chromosome 2q32 (affects >50% of cases of familial CMC; Blanco Lobo P et al. 2021).

CMC type 8 (CANDF8; OMIM:615527) mutation in the TRAF3IP2 gene (607043) at chromosome 6q21.

Type 9(CANDF9; OMIM:616445) mutation in IL17RC gene (610925) at chromosome 3p25.

LiteratureThis section has been translated automatically.

  1. Sheng R et al.(2021) The Role of CARD9 Deficiency in Neutrophils. Mediators Inflamm 4:6643603.
  2. Zhong X et al. (2018) Molecular and physiological roles of the adaptor protein CARD9 in immunity. Cell Death and Disease 9: 52.
  3. Zuccarello D et al. (2002) Familial chronic nail candidiasis with ICAM-1 deficiency: a new form of chronic mucocutaneous candidiasis. J Med Genet 39: 671-675.

Last updated on: 15.04.2022